Ask AI
ProCE Banner Activity

First to See, First to Act: Empowering NPs and PAs With Frontline Strategies to Recognize and Treat ATTR-CM

Slideset

Expert-curated slides on the pathogenesis of transthyretin amyloidosis cardiomyopathy (ATTR-CM) and strategies for diagnosing patients and personalizing their treatment with novel ATTR-CM therapies.

Released: December 05, 2025

Share

Provided by

Provided by Partners for Advancing Clinical Education (Partners) in partnership with the the Academy of Physician Associates in Cardiology (APAC).

ProCE Banner

Supporters

This activity is supported by an educational grant from Alnylam Pharmaceuticals.

Alnylam Pharmaceuticals

Partners

Academy of Physician Associates in Cardiology (APAC)

ProCE Banner

Target Audience

This activity is intended for cardiology-focused nurse practitioners, physician associates, clinical nurse specialists, and advanced degree nurses.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Identify the burden, signs, and clinical manifestations of ATTR-CM to facilitate prompt, precise, and thorough diagnosis

  • Formulate individualized treatment strategies using novel disease-modifying therapies to improve patient outcomes

  • Empower patients to understand their ATTR-CM diagnosis and the clinical rationale for disease-modifying therapies, addressing concerns about safety and progression while providing practical strategies to support treatment adherence through shared decision-making